AI assistant
Sending…
Traws Pharma, Inc. — Director's Dealing 2013
Jul 25, 2013
35199_dirs_2013-07-24_c994e43b-b4ad-4911-99aa-ff2f2f060e54.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-24
Reporting Person: GROOPMAN JEROME (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to purchase) | $1.33 | 2015-03-10 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $1.33 | 2015-04-27 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $2.67 | 2015-10-07 | Common Stock (750) | Direct | |
| Stock Option (right to purchase) | $2.67 | 2015-10-20 | Common Stock (1500) | Direct | |
| Stock Option (right to purchase) | $2.67 | 2016-01-12 | Common Stock (1500) | Direct | |
| Stock Option (right to purchase) | $2.67 | 2016-10-06 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2017-01-11 | Common Stock (1500) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2017-01-11 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2017-02-26 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2017-03-06 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2017-03-29 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2017-05-08 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2018-01-01 | Common Stock (2250) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2018-01-16 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2018-02-12 | Common Stock (187) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2018-06-01 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $6.13 | 2022-01-01 | Common Stock (2625) | Direct | |
| Stock Option (right to purchase) | $6.13 | 2021-06-06 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $6.13 | 2021-01-01 | Common Stock (2250) | Direct | |
| Stock Option (right to purchase) | $6.13 | 2020-09-30 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $5.76 | 2020-01-02 | Common Stock (2250) | Direct | |
| Stock Option (right to purchase) | $5.76 | 2019-12-01 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $5.76 | 2019-09-30 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $5.76 | 2019-07-24 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $5.76 | 2019-03-25 | Common Stock (375) | Direct | |
| Stock Option (right to purchase) | $5.76 | 2019-02-21 | Common Stock (187) | Direct | |
| Stock Option (right to purchase) | $5.76 | 2019-01-02 | Common Stock (2250) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2018-09-11 | Common Stock (187) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2018-07-23 | Common Stock (187) | Direct | |
| Stock Option (right to purchase) | $6.00 | 2018-06-01 | Common Stock (375) | Direct |
More from Traws Pharma, Inc.
Annual Report
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Share Issue/Capital Change
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 8